GLENMARK THERAPEUTICS

LIVE

Serial Number

97976501

Owner

GLENMARK THERAPEUTICS INC., USA

Attorney

Maxim A. Voltchenko

First Use Date

Jul 6, 2022

Filing Date

Apr 4, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GLENMARK THERAPEUTICS Trademark

Serial Number: 97976501 • Registration: 7317749

GLENMARK THERAPEUTICS is a trademark filed by GLENMARK THERAPEUTICS INC., USA on April 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

GLENMARK THERAPEUTICS INC., USA (40 trademarks)

MAHWAH, NJ 07430

Entity Type: 03

Legal Representation

Attorney of Record

Maxim A. Voltchenko

667 trademarks filed View all →

Correspondence Address

Maxim A. Voltchenko KAPLAN BREYER SCHWARZ, LLP

317 George Street, Ste 320

New Brunswick, NJ 08901

United States

Trademark Details

Filing Date

April 4, 2022

Registration Date

February 27, 2024

First Use Anywhere

July 6, 2022

First Use in Commerce

August 1, 2022

Published for Opposition

September 20, 2022

Goods & Services

Pharmaceutical preparations, namely, contraceptive preparations; pharmaceutical preparations, namely, antacids, acid reducers for the management of heartburn

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 19, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 19, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 19, 2025 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 19, 2025 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 19, 2025 COAR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 27, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 27, 2024 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 25, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 24, 2024 CNPR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 15, 2023 GNRN

NON-FINAL ACTION E-MAILED

Dec 15, 2023 GNRT

SU - NON-FINAL ACTION - WRITTEN

Dec 15, 2023 CNRT

DIVISIONAL PROCESSING COMPLETE

Sep 18, 2023 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 31, 2023 AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 26, 2023 AITU

TEAS/EMAIL CORRESPONDENCE ENTERED

May 4, 2023 TEME

DIVISIONAL REQUEST RECEIVED

May 3, 2023 DRRR

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 3, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 3, 2023 TROA

TEAS REQUEST TO DIVIDE RECEIVED

May 3, 2023 ERTD

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 27, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 27, 2023 GNRT

SU - NON-FINAL ACTION - WRITTEN

Mar 27, 2023 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Feb 16, 2023 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 16, 2023 AITU

USE AMENDMENT FILED

Jan 18, 2023 IUAF

TEAS STATEMENT OF USE RECEIVED

Jan 18, 2023 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 15, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 20, 2022 NPUB

PUBLISHED FOR OPPOSITION

Sep 20, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 31, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 17, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 22, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 22, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 22, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 12, 2022 GNRN

NON-FINAL ACTION E-MAILED

May 12, 2022 GNRT

NON-FINAL ACTION WRITTEN

May 12, 2022 CNRT

ASSIGNED TO EXAMINER

May 11, 2022 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 8, 2022 NWOS

NEW APPLICATION ENTERED

Apr 7, 2022 NWAP

Related Trademarks

More from this Owner

Serial #97404115

GLENMARK THERAPEUTICS

GLENMARK THERAPEUTICS INC., USA

GLENMARK THERAPEUTICS

More in Same Class